Psoriasis is a chronic, immune-mediated, inflammatory systemic disease which target primarily the skin. It presents a genetic basis, affecting 1 to 3% of the white population. Nevertheless, the existence of two psoriasis incidence peaks has been suggested (one in adolescence before 20 years of age and another in adulthood) onset may occur at any age, including childhood and adolescence, in which its prevalence ranges between 0.7% and 1.2%. As for adult psoriasis, pediatric psoriasis has recently been associated with obesity, metabolic syndrome, increased waist circumference percentiles, and metabolic laboratory abnormalities, warranting early monitoring and lifestyle modifications. In addition, due to psoriasis chronic nature and frequently occurring relapses, psoriatic patients tend to have an impaired quality of life, often requiring long-term treatment. Therefore, education of both pediatric patients and their parents is essential to successful and safe disease management. However, systemic treatment of children is challenging as the absence of standardized guidelines and the fact that evidence-based data form randomized controlled trials are very limited. This review shows an overview of the current understanding of the pathogenesis, comorbidities, differential diagnosis, treatment and prevention of pediatric psoriasis, also presenting with an emphasis on the necessity of an integrated treatment approach involving different specialists such as dermatologist, pediatricians, rheumatologists, etc.

Psoriasis in Children: a Review / Megna, Matteo; Napolitano, Maddalena; Balato, Anna; Scalvenzi, Massimiliano; Cirillo, T; Gallo, L; Ayala, Fabio; Balato, Nicola; Gallo, Lucia. - In: CURRENT PEDIATRIC REVIEWS. - ISSN 1573-3963. - 11:(2015), pp. 10-26. [10.2174/1573400511666150504125456]

Psoriasis in Children: a Review.

MEGNA, MATTEO;NAPOLITANO, MADDALENA;BALATO, ANNA;SCALVENZI, MASSIMILIANO;AYALA, FABIO;BALATO, NICOLA;GALLO, LUCIA
2015

Abstract

Psoriasis is a chronic, immune-mediated, inflammatory systemic disease which target primarily the skin. It presents a genetic basis, affecting 1 to 3% of the white population. Nevertheless, the existence of two psoriasis incidence peaks has been suggested (one in adolescence before 20 years of age and another in adulthood) onset may occur at any age, including childhood and adolescence, in which its prevalence ranges between 0.7% and 1.2%. As for adult psoriasis, pediatric psoriasis has recently been associated with obesity, metabolic syndrome, increased waist circumference percentiles, and metabolic laboratory abnormalities, warranting early monitoring and lifestyle modifications. In addition, due to psoriasis chronic nature and frequently occurring relapses, psoriatic patients tend to have an impaired quality of life, often requiring long-term treatment. Therefore, education of both pediatric patients and their parents is essential to successful and safe disease management. However, systemic treatment of children is challenging as the absence of standardized guidelines and the fact that evidence-based data form randomized controlled trials are very limited. This review shows an overview of the current understanding of the pathogenesis, comorbidities, differential diagnosis, treatment and prevention of pediatric psoriasis, also presenting with an emphasis on the necessity of an integrated treatment approach involving different specialists such as dermatologist, pediatricians, rheumatologists, etc.
2015
Psoriasis in Children: a Review / Megna, Matteo; Napolitano, Maddalena; Balato, Anna; Scalvenzi, Massimiliano; Cirillo, T; Gallo, L; Ayala, Fabio; Balato, Nicola; Gallo, Lucia. - In: CURRENT PEDIATRIC REVIEWS. - ISSN 1573-3963. - 11:(2015), pp. 10-26. [10.2174/1573400511666150504125456]
File in questo prodotto:
File Dimensione Formato  
Psoriasis in chikldren.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Accesso privato/ristretto
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/609123
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 29
social impact